May 05, 2011

Sanofi-aventis and Medicines for Malaria Venture Join Forces to Develop Innovative Malaria Drugs

 

Sanofi-aventis and Medicines for Malaria Venture Join Forces to Develop Innovative Malaria Drugs

Paris, France – May 5, 2011 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Medicines for Malaria Venture (MMV) announced today that they have signed an alliance agreement to research malaria treatments as well as the first research project agreement within the framework of the alliance.